Thermo Fisher Scientific Inc. historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2025-10-31 | 551.92 | 569.92 | 551.87 | 567.39 | 565.40 | 1,872,200 |
| 2025-10-30 | 551.60 | 565.63 | 551.60 | 556.22 | 554.27 | 1,315,100 |
| 2025-10-29 | 558.31 | 571.57 | 555.06 | 558.31 | 556.35 | 1,953,600 |
| 2025-10-28 | 564.13 | 565.65 | 555.57 | 557.63 | 555.68 | 992,700 |
| 2025-10-27 | 572.09 | 572.67 | 561.04 | 563.78 | 561.81 | 1,563,600 |
| 2025-10-24 | 574.15 | 575.82 | 569.79 | 572.50 | 570.50 | 1,655,700 |
| 2025-10-23 | 567.90 | 578.24 | 562.38 | 571.91 | 569.91 | 1,979,300 |
| 2025-10-22 | 555.50 | 571.29 | 550.88 | 567.20 | 565.21 | 3,461,200 |
| 2025-10-21 | 559.08 | 568.39 | 553.74 | 557.99 | 556.04 | 3,932,400 |
| 2025-10-20 | 541.00 | 550.46 | 540.00 | 543.84 | 541.94 | 1,665,200 |
← NewerPage 5 of 5 · 250 trading days
Stock splits
| Date | Split (new : old) |
|---|---|
| 1996-06-06 | 3:2 |
| 1995-05-25 | 3:2 |
| 1993-10-29 | 3:2 |
Dividends
| Ex-date | Amount |
|---|---|
| 2026-09-15 | 0.4700 USD |
| 2026-06-15 | 0.4700 USD |
| 2026-03-13 | 0.4700 USD |
| 2025-12-15 | 0.4300 USD |
| 2025-09-15 | 0.4300 USD |
| 2025-06-13 | 0.4300 USD |
| 2025-03-14 | 0.4300 USD |
| 2024-12-13 | 0.3900 USD |
| 2024-09-13 | 0.3900 USD |
| 2024-06-14 | 0.3900 USD |
| 2024-03-14 | 0.3900 USD |
| 2023-12-14 | 0.3500 USD |
| 2023-09-14 | 0.3500 USD |
| 2023-06-14 | 0.3500 USD |
| 2023-03-14 | 0.3500 USD |
| 2022-12-14 | 0.3000 USD |
| 2022-09-14 | 0.3000 USD |
| 2022-06-14 | 0.3000 USD |
| 2022-03-15 | 0.3000 USD |
| 2021-12-14 | 0.2600 USD |
| 2021-09-14 | 0.2600 USD |
| 2021-06-14 | 0.2600 USD |
| 2021-03-15 | 0.2600 USD |
| 2020-12-14 | 0.2200 USD |
| 2020-09-14 | 0.2200 USD |
| 2020-06-12 | 0.2200 USD |
| 2020-03-13 | 0.2200 USD |
| 2019-12-16 | 0.1900 USD |
| 2019-09-16 | 0.1900 USD |
| 2019-06-13 | 0.1900 USD |
| 2019-03-14 | 0.1900 USD |
Open, high, low and close are as traded (USD). Adjusted close accounts for splits and dividends. Educational only, not financial advice.